Atrial Dyssynchrony Measured by Strain Echocardiography as a Marker of Proarrhythmic Remodeling and Oxidative Stress in Cardiac Surgery Patients
Table 1
Demographics and medication of patients before surgery.
Variables
Dyssynchronous ()
Synchronous ()
value
Demographics
Age in years ()
0.262
Patient sex (male)
15 (71.4)
16 (66.6)
0.731
Type of surgery: coronary
20 (95.2)
21 (87.5)
0.559
Coronary disease
20 (95.2)
23 (95.8)
0.923
Diabetes mellitus
13 (61.9)
10 (41.6)
0.175
Hypertension
20 (95.2)
22 (91.6)
0.632
Dyslipidemia
19 (90.5)
20 (83.3)
0.482
Dilated cardiomyopathy
4 (19.0)
1 (4.2)
0.113
Chronic pulmonary obstructive disease
1 (4.8)
3 (12.5)
0.363
Chronic renal failure
3 (14.3)
1 (4.2)
0.234
Obesity
10 (47.6)
8 (33.3)
0.329
Stroke
0
1 (4.2)
0.344
Heart failure in last month
3 (14.3)
5 (20.8)
0.567
Smoker
2 (9.5)
4 (16.6)
0.482
Presurgical medications
Aspirin use
21 (100)
24 (100)
1
β Blocker use
15 (71.4)
17 (70.8)
0.965
Statins
20 (95.2)
24 (100)
0.280
ACEI or ARA
15 (71.5)
14 (58.3)
0.360
Spironolactone or eplerenone
5 (23.8)
2 (8.3)
0.153
Furosemide
3 (14.3)
2 (8.3)
0.526
Data are expressed as number and (%), unless otherwise indicated. values are calculated by Kruskal-Wallis test or chi-square test. ACEI: angiotensin-converting enzyme inhibitors; ARA: angiotensin II, type 1 receptor antagonists.
